Data driven evaluation of healthy volunteer characteristics at screening for phase I clinical trials to inform on study design and optimize screening processes
Abstract Protocols for clinical trials describe inclusion and exclusion criteria based on general and compound‐specific considerations to ensure subject safety and data quality. In phase I clinical trials, healthy volunteers (HVs) are screened against these criteria that often specify predefined eli...
Guardado en:
Autores principales: | Annemie Deiteren, Erwin Coenen, Sabine Lenders, Peter Verwilst, Erik Mannaert, Freya Rasschaert |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/4235eb3060a14b7e8e5f2d52ef5832b6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
por: Corey A Kalbaugh, et al.
Publicado: (2021) -
A phase I single-blind clinical trial to evaluate the safety of oil palm phenolics (OPP) supplementation in healthy volunteers
por: Syed Fairus, et al.
Publicado: (2018) -
Population pharmacokinetics of olprinone in healthy male volunteers
por: Kunisawa T, et al.
Publicado: (2014) -
Preventiometer, a Novel Wellness Assessment Device, Used With Healthy Volunteers: A Phase 2 Study
por: Sanjeev Nanda MD, et al.
Publicado: (2021) -
Feasibility of two screen media reduction interventions: Results from the SCREENS pilot trial.
por: Martin G B Rasmussen, et al.
Publicado: (2021)